| Patents for C12N 5 - Undifferentiated human, animal or plant cells, e.g. cell lines; Tissues; Cultivation or maintenance thereof; Culture media therefor (182,629) |
|---|
| 01/31/2003 | CA2391117A1 Pde10 cell-based assay and sequences |
| 01/30/2003 | WO2003008618A2 Glucans and glucansucrases derived from lactic acid bacteria |
| 01/30/2003 | WO2003008592A1 Polyfunctional stem cells originating in adipose tissue |
| 01/30/2003 | WO2003008579A2 Polynucleotides expressed in dendritic cells and polypeptides encoded thereby |
| 01/30/2003 | WO2003008577A1 Novel transformed cells, method of screening antiaging agent and antiaging agents |
| 01/30/2003 | WO2003008575A2 Dna sequences for regulating transcription |
| 01/30/2003 | WO2003008574A1 Mutations in ion channels |
| 01/30/2003 | WO2003008573A2 Silencing of gene expression by sirna |
| 01/30/2003 | WO2003008566A1 Production of radial glial cells |
| 01/30/2003 | WO2003008560A2 A novel g protein-coupled receptor, gave8 |
| 01/30/2003 | WO2003008558A2 Cd4+cd25+ inhibitory hybridoma clones |
| 01/30/2003 | WO2003008548A2 Mouse farnesoid x receptor sequences for use in comparative pharmacology |
| 01/30/2003 | WO2003008537A2 Epitope sequences |
| 01/30/2003 | WO2003008535A2 Methods of generating human cardiac cells and tissues and uses thereof |
| 01/30/2003 | WO2003008455A1 Activity monitor molecules for g-protein trimer |
| 01/30/2003 | WO2003008454A2 Glycoprotein vi fusion proteins |
| 01/30/2003 | WO2003008452A2 Bispecific monoclonal antibodies to il-12 and il-18 receptors |
| 01/30/2003 | WO2003008451A2 Modification of human variable domains |
| 01/30/2003 | WO2003008449A1 Ntb-a, a surface molecule involved in natural killer cells activity |
| 01/30/2003 | WO2003008448A2 Novel human proton-gated channels |
| 01/30/2003 | WO2003008374A1 Inhibitors of the ice/ced-3 family of cysteine proteases |
| 01/30/2003 | WO2003008102A1 Microfluidic gravity pump with constant flow rate |
| 01/30/2003 | WO2003007987A2 Haptenizing cancer cell components for the preparation of cancer vaccines |
| 01/30/2003 | WO2003007890A2 Tropomyosin isoforms, and diagnostic and therapeutic uses therefor |
| 01/30/2003 | WO2003007889A2 Therapeutic agents comprising pro-apoptotic proteins |
| 01/30/2003 | WO2003007886A2 Plant ion channels and methods |
| 01/30/2003 | WO2003007880A2 Inhibition of behab cleavage and primary central nervous system (cns) tumors |
| 01/30/2003 | WO2003007879A2 Cartilage repair and regeneration scaffold and method |
| 01/30/2003 | WO2003007873A2 Plasma protein matrices and methods for their preparation |
| 01/30/2003 | WO2003007869A2 Immunogenic compositions containing antigens, gene vectors and adjuvants-loaded biodegradable microspheres |
| 01/30/2003 | WO2003007805A2 Cartilage repair apparatus and method |
| 01/30/2003 | WO2003007800A2 Methods for diagnosing and treating diseases and conditions of the digestive system and cancer |
| 01/30/2003 | WO2003007795A2 Tissue engineered heart valve |
| 01/30/2003 | WO2003007790A2 Hybrid biologic/synthetic porous extracellular matrix scaffolds |
| 01/30/2003 | WO2003007787A2 Cartilage repair and regeneration device and method |
| 01/30/2003 | WO2003007786A2 Porous delivery scaffold and method |
| 01/30/2003 | WO2002092756A3 Insulin producing cells derived from human embryonic stem cells |
| 01/30/2003 | WO2002083187A9 Systems and methods for inducing mixed chimerism |
| 01/30/2003 | WO2002079478A3 Modification of organelle metabolism by a composition comprising unc-51-like kinases, roma1, or 2tm polypeptides and uses thereof for the preration of a medicament for the treatment disorders |
| 01/30/2003 | WO2002068585A9 Tip39 polypeptides |
| 01/30/2003 | WO2002051355A3 Acetyl-coenzyme a carboxylase 2 as a target in fat regulation and insulin action |
| 01/30/2003 | WO2002050257A3 Method for the production of polyfructans |
| 01/30/2003 | WO2002048333A3 Novel human kinases and uses thereof |
| 01/30/2003 | WO2002045523A3 Protein hydrolysates enriched in peptides having a carboxy terminal proline residue |
| 01/30/2003 | WO2002034879A3 Method for introducing antisense oligonucleotides into eucaryotic cells |
| 01/30/2003 | WO2002029410A3 Cells having a spectral signature, and methods of preparation and use thereof |
| 01/30/2003 | WO2002026988A3 Human drug metabolizing enzymes |
| 01/30/2003 | WO2002020763A3 Isolated human transporter proteins, nucleic acid molecules encoding human transporter proteins, and uses thereof |
| 01/30/2003 | WO2002017858A3 Role of fosb in bone formation |
| 01/30/2003 | WO2002016567A3 Isolated human kinase proteins, nucleic acid molecules encoding human kinase proteins, and uses thereof |
| 01/30/2003 | WO2002010393A3 Isolated nucleic acid molecules which encode t cell inducible factors, or interleukin-21, the proteins encoded, and uses thereof |
| 01/30/2003 | WO2002010362A3 Methods of controlling gene expression and gene silencing |
| 01/30/2003 | WO2002004599A3 Placental protein having multiple egf-like domains |
| 01/30/2003 | WO2002003052A9 Laser scanning cytology with digital image capture |
| 01/30/2003 | WO2002002634A3 Human extracellular matrix and cell adhesion polypeptides |
| 01/30/2003 | WO2001092877A3 Method of identifying and/or isolating stem cells |
| 01/30/2003 | WO2001090359A3 G-protein coupled receptors |
| 01/30/2003 | WO2001079286A3 Compositions and methods for the therapy and diagnosis of breast cancer |
| 01/30/2003 | WO2001064877A9 Human schizophrenia gene |
| 01/30/2003 | US20030024011 Plant oils with altered oleic acid content |
| 01/30/2003 | US20030024010 Genes for plant fatty acid modifying enzymes associated with conjugated double bond formation |
| 01/30/2003 | US20030024001 Animal models for use in the treatment of psychological and nervous system disorders |
| 01/30/2003 | US20030023997 Transgenic c. elegans as a model organism for investigations on alzheimer's disease |
| 01/30/2003 | US20030023994 Assay for toxin induced neuronal degeneration and viability in C. elegans |
| 01/30/2003 | US20030023993 Nucleotide sequences coding polypeptide for use in the treatment of necrosis, septic shock and inflammation |
| 01/30/2003 | US20030023990 Jnk3 modulators and methods of use |
| 01/30/2003 | US20030023074 Galanin receptor GALR3 and nucleotides encoding same |
| 01/30/2003 | US20030023070 For diagnosis, prophylaxis and therapy; therapy of cancer |
| 01/30/2003 | US20030023061 Family of genes encoding apoptosis-related peptides, peptides encoded thereby and methods of use thereof |
| 01/30/2003 | US20030023057 Used in assaying for cancer, such as melanoma |
| 01/30/2003 | US20030023056 In immunogenic preparations or diagnostic applications |
| 01/30/2003 | US20030023054 Secreted and transmembrane polypeptides and nucleic acids encoding the same |
| 01/30/2003 | US20030023045 Reshaped human antibody to human medulloblastoma cells |
| 01/30/2003 | US20030023038 For therapy of undesired cell proliferation; for stimulation and inhibition of lymphocytes |
| 01/30/2003 | US20030023033 Novel class II cytokine receptors and uses thereof |
| 01/30/2003 | US20030022860 CD40 binding molecules and CTL peptides for treating tumors |
| 01/30/2003 | US20030022858 Genes involved in the DNA regulation cascade (cell cycle disorders, DNA repair, tumorigenesis/tumor progression) which are associated with pathophysiology phenotype of Fanconi anaemia |
| 01/30/2003 | US20030022855 Melanoma differentiation associated gene-5 (mda-5) nucleic acids, proteins, and gene promoters for induction of apoptotic cell death |
| 01/30/2003 | US20030022850 Isolated nucleic acid molecule that hybridizes under stringent conditions or shares 80% sequence identity with a defined genomic region upstream of coding region of G-CSF gene, and DNA construct containing that DNA molecule as target |
| 01/30/2003 | US20030022849 Nucleic acid vaccines for prevention of flavivirus infection |
| 01/30/2003 | US20030022847 Administering antibiotics of quinolones, quinones, aminoglycosides or chloramphenicol to an individual under ischemic condition which lacks an adequate supply of oxygen and glucose |
| 01/30/2003 | US20030022837 Providing a cell undergoing mitosis with an Emi1 polypeptide, wherein anaphase promoting complex activity in proliferating cell is inhibited |
| 01/30/2003 | US20030022834 Methods and devices for promoting endothelial morphogenesis |
| 01/30/2003 | US20030022825 An isolated polynucleotide encoding a polypeptide having stem cell growth factor activity, said polynucleotide hybridizes to the complement of above polynucleotide under stringent hybridization conditions |
| 01/30/2003 | US20030022822 Novel compounds |
| 01/30/2003 | US20030022378 Expression vector for use as transfer tool in genetic engineering |
| 01/30/2003 | US20030022375 Expression vector for use as tool in gene therapy |
| 01/30/2003 | US20030022374 Modulating photoreactivity in a cell |
| 01/30/2003 | US20030022372 Embryogenesis process for initiation and maturation |
| 01/30/2003 | US20030022371 Antifreeze polypeptides for use in prefeation of frozen foods |
| 01/30/2003 | US20030022370 Magnetic immobilization of cells |
| 01/30/2003 | US20030022369 Differentiation of specialized dermal and epidermal cells into neuronal cells |
| 01/30/2003 | US20030022368 Suppression of differentiation in pluripotent stem cells; obtain stem cells, incubate with suppressor polypetide, monitor cell differentiation |
| 01/30/2003 | US20030022367 Cells for use as models in the treatment of heart defects |
| 01/30/2003 | US20030022366 Method for increasing survival rate of cells in animal cell culture under hypoxia condition |
| 01/30/2003 | US20030022354 Protein c derivatives |
| 01/30/2003 | US20030022339 Isolated human kinase proteins, nucleic acid molecules encoding human kinase proteins, and uses thereof |
| 01/30/2003 | US20030022338 Kunitz-type protease inhibitor polynucleotides, polypeptides, and antibodies |
| 01/30/2003 | US20030022336 Enzymatic polypeptide for use in the diagnosis of diabetes |
| 01/30/2003 | US20030022333 Preservation of samples by dehydration; obtain sample, dry, cool and store on shell |